A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy

Launched by FUJIAN CANCER HOSPITAL · Oct 21, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how to better predict which patients with cervical cancer might develop distant metastasis, meaning the cancer spreads to other parts of the body, after they receive radiotherapy. The goal is to identify those who may benefit from additional treatments and closer follow-up care. If you are a woman diagnosed with cervical cancer and have been treated with radiotherapy, you might be eligible to participate in this study.

To join, you should have been confirmed to have cervical cancer through a biopsy and completed radiotherapy. However, patients who have had surgery for cancer, incomplete treatments elsewhere, or certain medical histories may not qualify. If you participate, you can expect to help researchers gather important information that could lead to better treatment strategies for future patients. This trial is currently not recruiting participants, but it aims to make significant contributions to cervical cancer care.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • patients confirmed as cervical cancer by biopsies and treated with radiotherapy were initially enrolled
• Exclusion Criteria:
• • (1) patients treated with surgery. (2) patient received incomplete treatment somewhere else. (3) patients with cancer history. (4) patients with pelvic surgery history. (5) patients without complete pre-treatment medical information. (6) patients with unfinished radical radiotherapy. (7) patients suffered from metastasis within 3 months after radiotherapy. (8) patients without complete 1-year follow-up materials